Company · CIK 1849296
OKYO Pharma Ltd
| CIK | 1849296 (SEC EDGAR) |
|---|---|
| Industry (SIC) | 2836 — Biological Products, (No Diagnostic Substances) |
| Business address | United Kingdom |
| Listed | OKYO (Nasdaq) |
| First annual or quarterly report | 2022-08-15 |
Offerings
5 registrations| Registration | Label and status | First filed | Last event | Filings |
|---|---|---|---|---|
| 333-293145 | 2026-02-02 | 2026-02-17 | 5 | |
| 333-272516 | 2023-06-08 | 2025-06-11 | 9 | |
| 333-272005 | 2023-05-17 | 2023-06-14 | 5 | |
| 333-268675 | 2022-12-05 | 2023-03-14 | 10 | |
| 333-263326 | 2022-03-04 | 2022-05-18 | 9 |
Filings
42| Filed | Filing | Registration | Accession |
|---|---|---|---|
| 2026-02-17 | 424B5Shelf takedown | 333-293145 | 0001493152-26-006946 |
| 2026-02-12 | 424B5Shelf takedown | 333-293145 | 0001493152-26-006417 |
| 2026-02-11 | 424B5Shelf takedown | 333-293145 | 0001493152-26-006039 |
| 2026-02-10 | EFFECTDeclared effective | 333-293145 | 9999999995-26-000520 |
| 2026-02-02 | F-3Shelf registered | 333-293145 | 0001493152-26-004784 |
| 2025-06-11 | 424B5Shelf takedown | 333-272516 | 0001641172-25-014579 |
| 2023-12-20 | 424B5Shelf takedown | 333-272516 | 0001493152-23-045624 |
| 2023-12-18 | 424B5Shelf takedown | 333-272516 | 0001493152-23-045109 |
| 2023-10-31 | 424B5Shelf takedown | 333-272516 | 0001493152-23-038875 |
| 2023-09-15 | 424B5Shelf takedown | 333-272516 | 0001493152-23-032703 |
| 2023-09-13 | 424B5Shelf takedown | 333-272516 | 0001493152-23-032481 |
| 2023-07-28 | 424B5Shelf takedown | 333-272516 | 0001493152-23-025933 |
| 2023-06-14 | EFFECTDeclared effective | 333-272516 | 9999999995-23-001755 |
| 2023-06-14 | EFFECTDeclared effective | 333-272005 | 9999999995-23-001750 |
| 2023-06-09 | F-1/AAmendment | 333-272005 | 0001493152-23-020718 |
| 2023-06-08 | F-1/AAmendment | 333-272005 | 0001493152-23-020572 |
| 2023-06-08 | F-3Shelf registered | 333-272516 | 0001493152-23-020567 |
| 2023-06-02 | F-1/AAmendment | 333-272005 | 0001493152-23-020034 |
| 2023-05-17 | F-1Registration filed | 333-272005 | 0001493152-23-017939 |
| 2023-03-14 | 424B4Final prospectus | 333-268675 | 0001493152-23-007596 |
| 2023-03-08 | EFFECTDeclared effective | 333-268675 | 9999999995-23-000543 |
| 2023-02-27 | EFFECTDeclared effective | 333-268675 | 9999999995-23-000488 |
| 2023-02-22 | F-1/AAmendment | 333-268675 | 0001493152-23-005751 |
| 2023-02-17 | F-1/AAmendment | 333-268675 | 0001493152-23-005437 |
| 2023-01-19 | F-1/AAmendment | 333-268675 | 0001493152-23-001850 |
| 2023-01-12 | RWWithdrawn | 333-268675 | 0001493152-23-001282 |
| 2023-01-03 | F-1/AAmendment | 333-268675 | 0001493152-23-000158 |
| 2022-12-09 | F-1/AAmendment | 333-268675 | 0001493152-22-034990 |
| 2022-12-05 | F-1Registration filed | 333-268675 | 0001493152-22-034473 |
| 2022-11-17 | DRSDraft made public | 377-06462 | 0001493152-22-032681 |
| 2022-05-18 | 424B4Final prospectus | 333-263326 | 0001493152-22-014266 |
| 2022-05-16 | EFFECTDeclared effective | 333-264685 | 9999999995-22-001496 |
| 2022-05-16 | EFFECTDeclared effective | 333-263326 | 9999999995-22-001489 |
| 2022-05-13 | F-1/AAmendment | 333-263326 | 0001493152-22-013301 |
| 2022-05-09 | F-1/AAmendment | 333-263326 | 0001493152-22-012479 |
| 2022-05-04 | F-1/AAmendment | 333-263326 | 0001493152-22-011966 |
| 2022-04-26 | F-1/AAmendment | 333-263326 | 0001493152-22-011214 |
| 2022-04-14 | F-1/AAmendment | 333-263326 | 0001493152-22-009957 |
| 2022-03-25 | F-1/AAmendment | 333-263326 | 0001493152-22-007784 |
| 2022-03-04 | F-1Registration filed | 333-263326 | 0001493152-22-006119 |
| 2021-08-23 | DRSDraft made public | 377-05402 | 0001213900-21-044387 |
| 2021-03-22 | DRSDraft made public | 377-04475 | 0001493152-21-006483 |